Developing gene therapies for severe genetic and orphan diseases.
Industry: Health Care
First Day Return: +58.3%
IPO Data | |
---|---|
IPO Date | 06/18/2013 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $101 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Cambridge, MA, United States |
Founded | 1992 |
Employees at IPO | 50 |
Website www.bluebirdbio.com |